Bacteriophage Therapy in Cystic Fibrosis: Emerging Strategies for Managing Chronic Pseudomonas aeruginosa Infections
Drug Design, Development and Therapy · 2026
DOI: 10.2147/dddt.s612130 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2026. Verfasst von Ayona Puthenpurayil und 2 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Infection, Microbiology and Immunology (CIMI), University of Liverpool, Liverpool, UK. Hauptthemen laut MEDLINE: Cystic Fibrosis, Phage Therapy, Pseudomonas Infections, Pseudomonas aeruginosa. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Infection, Microbiology and Immunology (CIMI), University of Liverpool, Liverpool, UK.
ORCID-Profile: Ayona Puthenpurayil, Lauren Gordon, Joanne L Fothergill
Zitieren
APA
Puthenpurayil, A., Gordon, L., & Fothergill, J. L. (2026). Bacteriophage Therapy in Cystic Fibrosis: Emerging Strategies for Managing Chronic Pseudomonas aeruginosa Infections. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s612130
Vancouver
Puthenpurayil A, Gordon L, Fothergill JL. Bacteriophage Therapy in Cystic Fibrosis: Emerging Strategies for Managing Chronic Pseudomonas aeruginosa Infections. Drug Design, Development and Therapy. 2026. doi:10.2147/dddt.s612130
BibTeX
@article{Puthenpurayil2026,
author = {Puthenpurayil, Ayona and Gordon, Lauren and Fothergill, Joanne L},
title = {Bacteriophage Therapy in Cystic Fibrosis: Emerging Strategies for Managing Chronic Pseudomonas aeruginosa Infections},
journal = {Drug Design, Development and Therapy},
year = {2026},
doi = {10.2147/dddt.s612130}
}
EUVIMED